Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

4

Revenue 2017

Sanofi

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Sanofi's 2013 sales performance.

Sanofi

ACPs to lead gene therapies in haemophilia market growth

ACPs to lead gene therapies in haemophilia market growth inhibitors. Fitusiran, which Alnylam is co-developing with Sanofi, is in phase 3 trials for hemophilia A and B patients with or without inhibitors, and is expected to arrive on the

Amgen gets block on sales of Repatha rival in Germany

Amgen gets block on sales of Repatha rival in Germany Part of ongoing battle with Sanofi and Regeneron. Amgen has chalked up a win in its legal disputes with Sanofi and Regeneron over their cholesterol-lowering drugs, winning a sales injunction ... The Dusseldorf Regional Court found that Sanofi and

FDA verdict on Sanofi’s Darzalex rival is due in April 2020

FDA verdict on Sanofi’s Darzalex rival is due in April 2020 One of several anti-CD38 antibodies in pipeline. Johnson &Johnson’s multiple myeloma drug Darzalex has had the anti-CD38 category to itself since 2015, but could face competition from ... Sanofi has pointed to a shorter two-hour infusion for isatuximab

BioNTech raises €290m for mRNA cancer vaccine platform

BioNTech raises €290m for mRNA cancer vaccine platform The Mainz-based company – which specialises in drugs and vaccines based on messenger RNA (mRNA) and already has a string of big pharma partners including Pfizer, Sanofi, Roche, Eli Lilly and ... BioNTech also has a phase 1 trial on the go for a

NICE backs CDF funding for Sanofi/Regeneron’s skin cancer drug Libtayo

NICE backs CDF funding for Sanofi/Regeneron’s skin cancer drug Libtayo Acknowledges unmet need. Patients with a form of skin cancer will be able to access Sanofi/Regeneron's new checkpoint inhibitor Libtayo via the NHS in England, after funding for the ... However, Sanofi has agreed a managed access deal which makes the

[ Previous 5 results ] 8 9 10 11 12 13 14 15 16 17 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Language barriers: Obesity has become a loaded word
...
Spotlight interview: 15 minutes on digital in medical communications
Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications...
Generating data on long-term outcomes with gene and other advanced therapies
Gene therapy and advanced cell-based therapies offer patients hope and the potential to make them ‘chronically well’....

Infographics